Exhibit with us
*mymedicalexpo  
English
  1. Laboratory
  2. Laboratory medicine
  3. Neurodegenerative disease test kit
  4. Fujirebio
video corpo

Alzheimer test kit Lumipulse® G pTau 217 Plasma
for neurodegenerative diseasesfor phosphorylated tau proteinplasma

Alzheimer test kit - Lumipulse® G pTau 217 Plasma - Fujirebio - for neurodegenerative diseases / for phosphorylated tau protein / plasma
Alzheimer test kit - Lumipulse® G pTau 217 Plasma - Fujirebio - for neurodegenerative diseases / for phosphorylated tau protein / plasma
Add to favorites
Compare this product
Go to the Fujirebio website for more information

Characteristics

Applications
for alzheimer, for neurodegenerative diseases
Tested parameter
for phosphorylated tau protein
Sample type
plasma
Analysis mode
immunoassay, automated

Description

Product overview
Lumipulse® G pTau 217 Plasma is an in vitro diagnostic (IVD) assay for use on the automated LUMIPULSE G System for the quantitative measurement of Tau phosphorylated at threonine 217 (pTau 217) in human plasma (K2EDTA). The assay is intended to aid healthcare providers in identifying patients with amyloid pathology associated with Alzheimer’s disease. It is indicated for patients aged 50 years and over presenting with signs or symptoms of cognitive decline in a specialized care setting. For professional use only. The assay is intended to be used as an adjunct to other diagnostic evaluations.

Kit components / formats
  • Lumipulse® G pTau 217 Plasma Immunoreaction Cartridges — Product number: 81544 — Packaging: 3 x 14 Tests
  • Lumipulse® G pTau 217 Plasma Calibrators — Product number: 81545 — Packaging: 1 × 5 Concentrations

Regulatory / intended use notes
CE marked (IVDR). For in vitro diagnostic (IVD) use on the automated LUMIPULSE G System. For professional use only. Intended as an aid to identify amyloid pathology associated with Alzheimer’s disease and to be used as an adjunct to other diagnostic evaluations.

Technical characteristics / specifications
  • Analyte measured: Tau phosphorylated at threonine 217 (pTau 217)
  • Sample type: Human plasma (K2EDTA)
  • System compatibility: Automated LUMIPULSE G System
  • Intended population: Patients aged 50 years and over with signs or symptoms of cognitive decline (specialized care setting)
  • Purpose: Aid in identification of amyloid pathology associated with Alzheimer’s disease; adjunct to other diagnostic evaluations
  • Regulatory marking: CE marked (IVDR)
  • Available formats/products and codes: Immunoreaction Cartridges (81544, 3 x 14 Tests); Calibrators (81545, 1 × 5 Concentrations)
Go to the Fujirebio website for more information

Other Fujirebio products

Neurodegeneration

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.